FLAUM SANDER A 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Mar 6, 2019
Insider Transaction Report
Form 4
FLAUM SANDER A
Director
Transactions
- Exercise/Conversion
Common Stock
2019-03-05$4.04/sh+2,340$9,454→ 13,714 total - Tax Payment
Common Stock
2019-03-05$48.89/sh−204$9,974→ 13,510 total - Exercise/Conversion
Stock Option (right to buy)
2019-03-05−2,340→ 0 totalExercise: $4.04Exp: 2019-03-06→ Common Stock (2,340 underlying)
Footnotes (2)
- [F1]Represents shares withheld to satisfy the exercise price.
- [F2]These shares are fully vested and immediately exercisable.